FDA Advisors Consider Crispr Gene-Editing Treatment for Sickle Cell Anemia

FDA Advisors Consider Crispr Gene-Editing Treatment for Sickle Cell Anemia

Upworthy

Published

Sickle-cell disease has afflicted people of African descent for generations, causing agony and death among those who inherit its deformed red blood cells. The end of that unhappy inheritance inches closer on Tuesday—as the Food and Drug Administration asks a panel of experts to weigh in on what’s…

#african

Full Article